BSE Live
Nov 06, 09:34Prev. Close
844.45
Open Price
841.65
Bid Price (Qty.)
846.30 (86)
Offer Price (Qty.)
847.60 (5)
NSE Live
Nov 06, 09:34Prev. Close
844.60
Open Price
856.80
Bid Price (Qty.)
846.30 (1)
Offer Price (Qty.)
847.30 (2)
| Key Financial Ratios of Aarti Pharmalabs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 28.39 | 22.14 | 18.95 | 11.78 | -0.18 | |
| Diluted EPS (Rs.) | 28.38 | 22.14 | 18.95 | 11.78 | -0.18 | |
| Cash EPS (Rs.) | 37.12 | 29.42 | 25.10 | 31.60 | -0.18 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 203.44 | 178.92 | 158.74 | 281.87 | 9.07 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 203.44 | 178.92 | 158.74 | 281.87 | 9.07 | |
| Dividend / Share(Rs.) | 5.00 | 3.00 | 2.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 195.44 | 165.75 | 166.76 | 206.53 | 0.00 | |
| PBDIT/Share (Rs.) | 48.66 | 39.41 | 34.16 | 40.01 | -0.18 | |
| PBIT/Share (Rs.) | 39.94 | 32.13 | 28.01 | 31.84 | -0.18 | |
| PBT/Share (Rs.) | 37.11 | 30.29 | 25.75 | 29.35 | -0.18 | |
| Net Profit/Share (Rs.) | 28.39 | 22.14 | 18.95 | 23.42 | -0.18 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 24.89 | 23.77 | 20.48 | 19.37 | 0.00 | |
| PBIT Margin (%) | 20.43 | 19.38 | 16.79 | 15.41 | 0.00 | |
| PBT Margin (%) | 18.98 | 18.27 | 15.44 | 14.21 | 0.00 | |
| Net Profit Margin (%) | 14.52 | 13.35 | 11.36 | 11.34 | 0.00 | |
| Return on Networth / Equity (%) | 13.95 | 12.37 | 11.93 | 8.31 | -2.02 | |
| Return on Capital Employed (%) | 17.22 | 16.72 | 16.83 | 10.78 | -1.87 | |
| Return on Assets (%) | 9.44 | 8.73 | 8.74 | 5.84 | -1.83 | |
| Total Debt/Equity (X) | 0.21 | 0.15 | 0.14 | 0.25 | 0.00 | |
| Asset Turnover Ratio (%) | 0.71 | 0.71 | 0.80 | 1.03 | 0.00 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.95 | 2.04 | 2.11 | 1.85 | 54.40 | |
| Quick Ratio (X) | 1.07 | 0.99 | 0.93 | 0.93 | 54.40 | |
| Inventory Turnover Ratio (X) | 3.15 | 1.36 | 1.83 | 0.00 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 12.32 | 9.03 | 10.55 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 9.42 | 6.79 | 7.96 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 87.68 | 90.97 | 89.45 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 90.58 | 93.21 | 92.04 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 7,175.79 | 4,188.60 | 2,682.57 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 4.05 | 2.79 | 1.78 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 16.27 | 11.73 | 8.66 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 3.83 | 2.62 | 1.65 | 0.00 | 0.00 | |
| Retention Ratios (%) | 87.67 | 90.96 | 89.44 | 0.00 | 0.00 | |
| Price/BV (X) | 3.68 | 2.43 | 1.73 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 3.83 | 2.62 | 1.65 | 0.00 | 0.00 | |
| Earnings Yield | 0.04 | 0.05 | 0.07 | 0.00 | 0.00 |
22.09.2025
19.09.2025
15.05.2025
AARTIPHARM Standalone March 2025 Net Sales at Rs 529.62 crore, up 27.68% Y-o-Y
12.05.2025
AARTIPHARM Consolidated March 2025 Net Sales at Rs 563.78 crore, up 11.47% Y-o-Y
15.05.2025
AARTIPHARM Standalone March 2025 Net Sales at Rs 529.62 crore, up 27.68% Y-o-Y
12.05.2025
AARTIPHARM Consolidated March 2025 Net Sales at Rs 563.78 crore, up 11.47% Y-o-Y
06.02.2025
AARTIPHARM Consolidated December 2024 Net Sales at Rs 537.78 crore, up 19.86% Y-o-Y
06.02.2025
AARTIPHARM Standalone December 2024 Net Sales at Rs 470.95 crore, up 26.25% Y-o-Y